Developing the Most Sensitive and Specific Bladder Cancer Test

About Our Product

Bladder cancer is one of the major cancers of the urinary  system that is one of the most expensive cancers to treat due to a high recurrence rate

Typically, routine monitoring of bladder cancer is performed by cystoscopic examination and is invasive, painful, and expensive. Cystoscopy is often augmented by a non-invasive laboratory method such as urine cytology. However, these tests lack adequate sensitivity or specificity to significantly improve the diagnosis and treatment of bladder cancer patients. 

      URO17®️bladder cancer test is a        CE-Marked IVD product.


URO17®️ test recieved FDA breakthrough designation status and studies are in progress to achieve FDA clearance. 

50 years of


We have the know-how you need.

Our Story

Passion led us here.

At KDx Diagnostics, we believe in the advancement of bladder cancer recognition. Ever since our founding in 2016, we have worked endlessly to achieve the highest sensitivity and specificity test. With the creation of our URO17®️ bladder cancer test, we have achieved an inexpensive and non-invasive assay that is simpler to use for the patient with results that are more accurate than ever before. We hope with the introduction of the URO17®️, we can strive for quicker recognition and response to the dangers of cancer. Our goal is to help patients achieve a peaceful and care-free life.

Copyright © All Rights Reserved

LEGAL NOTICE; By accessing, browsing and/or otherwise using this website, you acknowledge that you have read, understood, and are bound by the KDx Diagnostics Inc. Website Terms and Conditions, and Privacy Policy and shall comply with all applicable laws and regulations. If you do not agree to these terms, do not use this website. Additionally, this website contains information on products that is targeted to many different audiences and may contain product details or information otherwise not accessible or valid in your country. Please be aware that KDx Diagnostics Inc. does not take any responsibility for your decision to access any such information on this website that may not comply with a legal process, regulation, registration or usage in the country of your origin.

Website Creator: Chelgis Jahanfard